Framing Product Value: What? Who? How?
Health Technology Assessment (HTA) and Patient Engagement
This engaging workshop took place on November 25, 2016 in Basel, Switzerland
Time 8:30 am -17:00 pm. The results have been presented as a poster at the 20th Annual European Congress (4-8 November 2017 in Glasgow, Scotland) – Please find the poster below.
This workshop can be offered in bespoke format to address the needs in your organization. It can be conducted as a team building day or in order to align collaborators in a development project around patient engagement.
Background
Healthcare markets in Europe and elsewhere are increasingly restricting patient access by health technology assessment (HTA) policies with growing focus on patient relevant outcomes and cost-effectiveness.
This interactive and exploratory course will give you important insights to integrate the expectations of regulators, payers and patients by making the focus on patient needs a key success factor of your pharmaceutical, diagnostic or med-tech product.
Workshop Content
Knowledge: Measurement of value in healthcare, HTA methods and patients’ perspectives on decision making, involvement of patients in shaping your products’ value proposition
Exploration: Understand the patient perspectives throughout the disease journey
Designed for:
• Researchers in the health-care industry (Pharma/Diagnostics/Med-Tech),
• Business development, Marketing, Clinical Development or other business areas interested in successful market access for their healthcare technologies or products
Faculty
Martina Dresler – Personality Coach & ARTherapIST
Gurmit Sandhu, B Pharm (Hons), MPH, MBM – Patient Engagement Specialist
Anke-Peggy Holtorf, PhD, MBA – Market Access & HTA Expert
You can find the Bios of the faculty here
REGISTRATION
Registration is closed.
For more information on this workshop, please contact us under value(@)health-os.com or Anke-Peggy Holtorf +41 61 383 0660
(and let us know who you are, please: Name / Company / Street / ZIP / City / Country / Telephone)